← Open Payments lookup

EDWARD LAZAGA: Open Payments

NPI 1396729547 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$929 in 34 payments from 8 companies in 2025. Trend: 2023 $787 · 2024 $716 · 2025 $929

Food & beverage: $929
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.11$444
Boehringer Ingelheim Pharmaceuticals, Inc.13$216
Travere Therapeutics, Inc.4$164
AstraZeneca Pharmaceuticals LP2$34
Calliditas Therapeutics US Inc.1$20
Ardelyx, Inc.1$19
Aurinia Pharma U.S., Inc.1$16
Amgen Inc.1$16

Products named: Kerendia, JARDIANCE, Filspari, FARXIGA, TARPEYO, IBSRELA, LUPKYNIS, KRYSTEXXA.

Industry payments across TX — which companies pay providers there.